D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2

Molecules and Cells

Volumn 26, Issue 5, 2008, Pages 481-485

  Kang, Mi Sun ^a   Jung, Sung Yun ^a   Jung, Kwang Mook ^a   Kim, Seok Kyun ^a   Ahn, Kyong Hoon ^a   Kim, Dae Kyong ^a  

^a Chung Ang University   (South Korea)

Author keywords

AA release; cPLA2; D609; DAG; MDCK cells; PC PLC

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C INHIBITOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELL STRAIN; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOSOL; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; IC 50; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACID; BRIDGED COMPOUNDS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; ENZYME INHIBITORS; GROUP IV PHOSPHOLIPASES A2; THIONES; TYPE C PHOSPHOLIPASES;

BOVINAE;

EID: 58049083763     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Amtmann, E. (1996). The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholi-pase C. Drugs. Exp. Clin. Res. 22, 287-294.
2. Andrei, C., Margiocco, P., Poggi, A., Lotti, L.V., Torrisi, M.R., and Rubartelli, A. (2004). Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. Proc. Natl. Acad. Sci. USA 101, 9745-9750.
3. 2 and signal transduction. J. Am. Soc. Nephrol. 3, 128-150.
4. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Cai, H., Erhardt, P., Szeberenyi, J., Diaz-Meco, M.T., Johansen, T., Moscat, J., and Cooper, G.M. (1992). Hydrolysis of phosphatidylcholine is stimulated by Ras proteins during mitogenic signal transduction. Mol. Cell. Biol. 12, 5329-5335.
6. Cai, H., Erhardt, P., Troppmair, J., Diaz-Meco, M.T., Sithanandam, G., Rapp, U.R., Moscat, J., and Cooper, G.M. (1993). Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol. Cell. Biol. 13, 7645-7651.
7. Cheng, J., Weber, J.D., Baldassare, J.J., and Raben, D.M., (1997). Ablation of Go alpha-subunit results in a transformed phenotype and constitutively active phosphatidylcholine-specific phospholipase C. J. Biol. Chem. 272, 17312-17319.
8. Cuschieri, J., Billgren, J., and Maier, R.V. (2006). Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J. Leukoc. Biol. 80, 407-414.
9. Diaz-Laviada, I., Larrodera, P., Diaz-Meco, M.T., Cornet, M.E., Guddal, P.H., Johansen, T., and Moscat, J. (1990). Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes. EMBO. J. 9, 3907-3912.
10. 2. Cell. Signal. 14, 199-204.
11. Exton, J.H. (1994). Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1212, 26-42.
12. Favaron, M., Manev, H., Siman, R., Bertolino, M., Szekely, A.M., DeErausquin, G., Guidotti, A., and Costa, E. (1990). Down-regulation of protein kinase C protects cerebellar granule neurons in primary culture from glutamate-induced neuronal death. Proc. Natl. Acad. Sci. USA 87, 1983-1987.
13. 2 activation. J. Leukoc. Biol. 65, 330-336.
14. Johansen, T., Bjorkoy, G., Overvatn, A., Diaz-Meco, M.T., Traavik, T., and Moscat, J. (1994). NIH 3T3 cells stably transfected with the gene encoding phosphatidylcholine hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. Mol. Cell. Biol. 14, 646-654.
15. 2, PLC, and PLD in bradykinin-induced release of arachidonic acid in MDCK cells. Am. J. Physiol. 271, C1064-C1072.
16. Kennedy, C.R., Hébert, R.L., Do, M.T., and Proulx, P.R. (1997). Bradykinin-stimulated arachidonic acid release from MDCK cells is not protein kinase C dependent. Am. J. Physiol. 273, C1605-1612.
17. 2 activity. Biochem. J. 294, 261-270.
18. 2 from bovine platelets. Biochem. Biophys. Res. Commun. 174, 189-196.
19. Kiss, Z., and Tomono, M. (1995). Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim. Biophys. Acta 1259, 105-108.
20. Li, Y., Maher, P., and Schubert, D. (1998). Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc. Natl. Acad. Sci. USA 95, 7748-7753.
21. 2 is phosphorylated and activated by MAP kinase. Cell 72, 269-278.
22. Luberto, C., and Hannun, Y.A. (1998). Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacyl-glycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J. Biol. Chem. 273, 14550-14559.
23. Machleidt, T., Kramer, B., Adam, D., Neumann, B., Schutze, S., Wiegmann, K., and Kronke, M. (1996). Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. J. Exp. Med. 184, 725-733.
24. 2+ release from intracellular stores evoked by alpha 1A- and alpha 2A-adrenoceptors in rat portal vein myocytes. Biochem. Biophys. Res. Commun. 218, 30-34.
25. 2+ receptor-stimulated hormone release from sheep thyroid para-follicular cell. J. Physiol. 502, 31-34.
26. Monick, M.M., Carter, A.B., Gudmundsson, G., Mallampalli, R., Powers, L.S., and Hunninghake, G.W. (1999). A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. J. Immunol. 162, 3005-3012.
27. Muller-Decker, K. (1989). Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem. Biophys. Res. Commun. 162, 198-205.
28. Nofer, J.R., Junker, R., Seedorf, U., Assmann, G., Zidek, W., and Tepel, M. (2000). D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes. Cell. Signal. 12, 289-296.
29. O'Flaherty, J.T., Chadwell, B.A., Kearns, M.W., Sergeant, S., and Daniel, L.W. (2001). Protein kinases C translocation responses to low concentrations of arachidonic acid. J. Biol. Chem. 276, 24743-24750.
30. Pastorino, J.G., Simbula, G., Yamamoto, K., Glascott, P.A., Rothman, R.J., and Farber, J.L. (1996). The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271, 29792-29798.
31. Pessin, M.S., and Raben, D.M., (1989). Molecular species analysis of 1,2-diglycerides stimulated by alpha-thrombin in cultured fibroblasts. J. Biol. Chem. 264, 8729-8738.
32. Pettitt, T.R., Martin, A., Horton, T., Liossis, C., Lord, J.M., and Wakelam, M.J. (1997). Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells. J. Biol. Chem. 272, 17354-17359.
33. Ramoni, C., Spadaro, F., Barletta, B., Dupuis, M.L., and Podo, F. (2004). Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp. Cell. Res. 299, 370-82.
34. 2 activity in human brain. J. Neurochem. 64, 2213-2221.
35. Schutze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., and Kronke, M. (1992). TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776.
36. 2+ influx by 2,2′,4,6-tetrachlorobiphenyl in PC12 cells. Toxicol. Appl. Pharmacol. 178, 37-43.
37. Temes, E., Martín-Puig, S., Aragonés, J., Jones, D.R., Olmos, G., Mérida, I., and Landázuri, M.O. (2004). Role of diacylglycerol induced by hypoxia in the regulation of HIF-1alpha activity. Biochem. Biophys. Res. Commun. 315, 44-50.
38. Tschaikowsky, K., Schmidt, J., and Meisner, M., (1998). Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. J. Pharmacol. Exp. Ther. 285, 800-804.
39. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D., and Kronke, M., (1994). Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005-1015.
40. 2-linked cascade, J. Biol. Chem. 275, 32357-32362.
41. 2 phosphorylation and arachadonic acid release in primary murine astrocytes. J. Neurochem. 83, 259-270.
42. You, H.J., Seo, J.M., Moon, J.Y., Han, S.S., Ko, Y.G., and Kim, J.H. (2007). Leukotriene synthesis in response to A23187 is inhibited by methyl- beta-cyclodextrin in RBL-2H3 cells. Mol. Cells 23, 57-63.
43. Zamorano, J., Rivas, M.D., Garcia-Trinidad, A., Qu, C.K., and Keegan, A.D. (2003). Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. J. Immunol. 171, 4203-4209.
44. Zhang, F., Zhao, G., and Dong, Z. (2001). Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells by lipopeptide JBT3002. J. Leukoc. Biol. 69, 1060-1066.
45. 2 induces apoptosis via a mechanism involving ceramide generation. Biochim. Biophys. Acta 1581, 75-88.